Kenya Home Healthcare Market Analysis

Kenya Home Healthcare Market Analysis
A sample report on

This report presents a strategic analysis of the Kenya Home
Healthcare Market and a forecast for its development in the medium
and long term. It provides a comprehensive overview of the market
value, dynamics, segmentation, main players, growth and demand
drivers, challenges & future outlook, etc. This is one of the most
comprehensive reports about the Kenya Home Healthcare Market,
and offers unmatched value, accuracy, and expert insights.

3
A Sample Report on Kenya Home Healthcare Market Analysis I Confidential
Report Scope
Report Attribute Details
Number of Pages 70-80
Base Year for Estimation 2022
Forecast Period 2023-2030
Report Coverage
Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends,
Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape,
Reimbursement Scenario
Quantitative Units Revenue in USD Million/Billion (Mn/Bn)
Research Approach Secondary Research (60%), Primary Research (40%)
Click on the icon to know the detailed methodology

4
Table of Content
CONTENT PG. NO.
1. Home Healthcare Overview 08-22
1.1. Overview
1.2. Kenya Overview
1.3. Economic Overview: Kenya
1.4. Home Healthcare Market in Kenya
1.5. OTC & Nutraceuticals Market in Kenya
1.6. Healthcare Scenario in Kenya
1.7. Health Insurance Coverage: Kenya
1.8. Budget of the Government for Public Insurance
1.9. Mergers and Acquisitions
2. Market Size and Forecasting 23-29
2.1. Market size and forecasts (Excel and Methodology)

5
Table of Content
CONTENT PG. NO.
2.2. Market Segmentation
2.2.1. By Service Type
2.2.2. By Indication Type
2.2.3. By Patient Type
2.2.4. By Product Type
3. Market Dynamics 30-34
3.1. Market Growth Drivers
3.1.1. Kenya Home Healthcare Market Driver 1
3.2. Market Restraints
3.2.1. Kenya Home Healthcare Market Restraint 1

6
Table of Content
CONTENT PG. NO.
4. Competitive Landscape 35-44
4.1. Key Company Profile
4.1.1. GoCare
4.1.2. Company 2
4.1.3. Company 3
4.1.4. Company 4
4.1.5. Company 5
4.1.6. Company 6
4.1.7. Company 7

7
Table of Content
CONTENT PG. NO.
4.1.8. Company 8
4.1.9. Company 9
4.1.10. Company 10
5. Reimbursement Scenario 45-47
5.1. Reimbursement Regulation
6. Methodology & Scope 48-53

1. Overview

9
1.1 Statistics at a Glance: Status of Home Healthcare in the World
Overview of Home Healthcare ▪ Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪ In this section you will get an
understanding of the topic, which includes
the prevalence of the disease, the
application of medical devices, new
technology, and other details related to the
topic
▪ In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪ Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
$247 Bn
Was the market size of Global
Home Healthcare in 2022
8.06%
Can be the exhibiting CAGR of
the Home Healthcare Market
from 2022-2030
1 in 6 People
Will be aged 65 or more by
2050
1 in 3 Adults
Suffer from chronic diseases
globally
Illustrative

10
1.1 Statistics at a Glance (continued)
North America
~Market Size of
$xx Bn
Europe
~Revenue to reach
$xx Bn by 2030
APAC
-Fastest CAGR
Africa
~Market Size of
$xx Bn
Kenya
~Market Size of
$xx Bn
Illustrative

11
1.2 Kenya Overview
▪ Please be aware that this sample report is
report
understanding of the demographics of the
country/region, which includes the
population, GDP, healthcare expenditure
and other details related to the topic
interest
53 Mn
Population of Kenya
in 2021
20.1
Is the median age
in Kenya, in 2020
113.42 Bn
Is the Gross
Domestic Product
(GDP) in Kenya in
2022
4.29%
of Kenya’s GDP is
spent on health in
2020
Illustrative

12
1.3 Economic Overview: Kenya
XX
XX
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
Population of Kenya, (2020-2030)
XX
XX
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
GDP of Kenya, (2020-2030)
Population Split (2023)
55-64
0-14
15-24
25-54
65+
Male
49%
Female
51%
By Age Group
By Gender
▪ In this section you will get an understanding of the demographics
of the country/region, which includes the population, GDP,
healthcare expenditure and other details related to the topic
▪ In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Illustrative

13
1.4 Kenya Statistics at a Glance
Kenya Home Healthcare Market
▪ Please be aware that this sample report
is intended to provide you with a brief
analysis that will be presented in the
final report
understanding of the topic, which
includes the prevalence of the disease,
the application of medical devices, new
technology, and other details related to
the topic in Kenya
information that you are seeking, you
will need to purchase the final report
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
2%
Expected growth in health
expenditure
67.5 years
Is the average life expectancy
of both sexes
15%
Covered under Kenya National
Hospital Fund
$ 83.4
is the Healthcare spending
per capita as of 2020
70%
Kenyans live in
rural areas without
easy access to
healthcare
Illustrative

14
1.5 Healthcare Services in Kenya
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Kenya Healthcare Services Market Forecast, 2022-2030 (in $Bn)
▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be
presented in the final report
▪ In this section you will get an understanding of the overall Home Healthcare market in Kenya, which includes the market size, current trends
▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or
Illustrative

15
1.6 Healthcare Scenario in Kenya
1. Universal Healthcare: Kenya has a universal healthcare system known as Public. It provides Kenyans with access to subsidized medical
services, including visits to general practitioners, specialist consultations, and public hospital services.
2. Primary Healthcare: Primary healthcare plays a vital role in Kenya's healthcare system. It involves general practitioners (GPs) who serve
as patients’ first point of contact. GPs provide preventive care, diagnose and treat common illnesses, and refer patients to specialists when
needed.
3. Public and Private Healthcare: Kenya has a mix of public and private healthcare sectors. Public hospitals are funded by the government
and provide free or low-cost services to eligible patients. Private healthcare offers additional services and options for those who have private
health insurance.
4. Pharmaceutical Benefits Scheme (PBS): The PBS subsidizes the cost of prescription medications, making them more affordable for
Kenyans. Under this scheme, patients pay a reduced price for medications listed on the PBS schedule.
5. Aged Care Services: Kenya has a well-developed aged care sector to cater to the needs of older adults. It includes residential aged care
facilities, home care services, and community-based programs.
6. Health Workforce: Kenya has a well-trained and diverse healthcare workforce, including doctors, nurses, allied health professionals, and
specialists. The country also welcomes international healthcare professionals to address workforce needs.
Illustrative
Healthcare scenario in Kenya is characterized by a robust system that aims to provide universal access to high-
quality healthcare services

16
1.6 Healthcare Scenario in Kenya (continued)
7. Health Promotion and Prevention: Kenya emphasizes health promotion and disease prevention initiatives. Various campaigns and
programs focus on promoting healthy lifestyles, disease screening, immunization, and early intervention.
8. Digital Health: The adoption of digital health technologies is increasing in Kenya. Electronic health records, telehealth services, and digital
health platforms are being used to improve access to healthcare and enhance coordination of care.
Illustrative
Healthcare scenario in Kenya is characterized by a robust system that aims to provide universal access to high-
quality healthcare services

17
1.7 Health Insurance Coverage: Kenya
1.0
30.9
35.7
2.5
3.5
10.2
54.3
66.0
91.7
8.3
VA and CHAMPVA
Public
Any public plan
TRICARE
Marketplace
Direct-purchase
Employment-based
Any private plan
With health insurance
Uninsured
▪ In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire
calendar year
▪ More people had private health insurance (66%) than public coverage (35.7%)
▪ Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%),
followed by Public (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care (1%)
Coverage Type 2020 2021 Change %
Total 327,521 328,074
Any health plan 299,230 300,887 0.4
Any private plan 217,896 216,366 –0.6
Employment-based 178,737 178,285 –0.2
Direct-purchase 33,869 33,555 –0.1
Marketplace coverage 10,924 11,389 0.1
TRICARE 9,165 8,299 –0.3
Any public plan 112,925 117,095 1.2
58,541 60,226 0.5
58,778 61,940 0.9
VA and CHAMPVA 2,967 3,151 0.1
Uninsured 28,291 27,187 –0.4
% of People by Type of Health Insurance Coverage
(2021)
Number of People By Health Insurance Coverage
Illustrative

18
1.7 Health Insurance Coverage: Kenya (continued)
Illustrative
1. Public Coverage: All Kenyan citizens and permanent residents are eligible for Public, which provides access to subsidized or free
healthcare services in public hospitals and subsidizes visits to general practitioners (GPs) and specialists.
2. Private Health Insurance: Private health insurance in Kenya is optional but widely used to supplement Public coverage. It provides
additional benefits, such as faster access to elective surgeries, choice of doctor or specialist, and coverage for ancillary services like dental
care, optical services, and physiotherapy.
3. Hospital Cover: Private health insurance in Kenya typically includes hospital cover, which helps cover the cost of hospitalization, surgeries,
and related medical treatments. It allows individuals to choose their preferred doctor and hospital for non-emergency procedures.
4. Extras Cover: Extras cover, also known as ancillary or general treatment cover, provides benefits for a range of non-hospital services,
including dental care, optical services, physiotherapy, chiropractic treatment, and more.
5. Public Levy Surcharge: Kenyans who earn above a certain income threshold and do not have private hospital cover may be subject to the
Public Levy Surcharge. This surcharge is an additional tax that aims to incentivize individuals to take up private health insurance.
6. Lifetime Health Cover: Lifetime Health Cover is a financial loading that can be applied to the premiums of private health insurance if an
individual does not take out hospital cover before the age of 31. The loading increases the longer an individual delays taking out private
hospital cover.
7. Rebates and Incentives: The Kenyan Government provides income-tested rebates to help lower the cost of private health insurance
premiums. The rebate amount depends on an individual's income and age. Additionally, individuals aged 18 to 29 may be eligible for the
Private Health Insurance Rebate (PHIR) incentive.

19
1.8 Budget of Kenya Government for Public Insurance
▪ National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP)
▪ Public spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE
▪ Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE
▪ Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE
▪ Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% of total NHE
▪ Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020
▪ Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020
▪ Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020
▪ Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health
spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7%
Illustrative
Proposed Budget By Category
Outlays 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31
In Billions Of Dollars
Public $769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633
Private $458 $521 $571 $582 $616 $645 $674 $698 $734 $768 $801 $837 $6,926
As % Of GDP
Public 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7%
Private 2.2% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.5% 2.5% 2.5% 2.5% 2.4%

20
1.9 Mergers and Acquisitions
$6.0
$7.7
$10.5
$16.7
$6.8
$11.7
1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022
82
112 107 107
89
110
1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022
57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020
RCM M&A Deal Value Trend ($Bn) RCM M&A Deal Volume Trend
Buyer Composition: Strategic Vs Financial (2020)
59%
41% 41%
59% 58%
42%
61%
39%
$0- $25 $25-$50 $50-$100 $100+
Strategic Buyers
Financial Buyers
Buyer Type by Deal Size
($Mn)
Illustrative

21
1.9 Mergers and Acquisitions (continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Latest Deals In Kenya
Illustrative

2. Market Size and Forecasting

23
2.1 Market Size and Forecasts (Excel and Methodology)
XX
XX
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Kenya Home Healthcare Market Forecast, 2022-2030 (in $Bn)
final report
understanding of the overall Healthcare
Insurance market in Malaysia, which
includes the market size, current trends
Click on the icon to know the
methodology and assumption
2023 2024 2025 2026 2027 2028 2029 2030
Major Markets Patient
(Mn)
2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12
Kenya Patient Size (Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73
% of Kenya Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45%
Global Market Size (Bn $) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937
Kenya Market Size (Bn $) 61 74 84 87 91 95 99 106
Illustrative

24
2.2 Snapshot of Kenya Home Healthcare Market Segmentation
▪ In this section you will get an understanding of the segmentations which will cover the Kenya Home Healthcare Market
Service Type
Unskilled Care
Service
Skilled Care
Service
Indication Type
Cancer
Respiratory
disease
Cardio Vascular
Disease
Hypertension
Wound Care
Diabetes
Pregnancy
Patient Type
Geriatric
Population
Pediatric
Population
Patient with
Chronic Disease
Product Type
Therapeutic
Equipment
Diagnostic
Equipment
Mobility Aids

25
Kenya Home Healthcare Market Share, By Service Type (2022)
Unskilled Care
Service
Skilled Care
Service
final report
2.2.1 Market Segmentation: By Service Type
Illustrative

26
Kenya Home Healthcare Market Share, By Indication Type (2022)
Cancer
Respiratory
Disease
Cardio Vascular
Hypertension
Wound Care
Diabetes
Pregnancy
2.2.2 Market Segmentation: By Indication Type
final report
Illustrative

27
Kenya Home Healthcare Market Share, By Patient Type (2022)
Geriatric
Population
Pediatric
Population
Patient with
Chronic Disease
2.2.3 Market Segmentation: By Patient Type
final report
Illustrative

28
Kenya Home Healthcare Market Share, By Product Type (2022)
Therapeutic
Equipment
Diagnostic
Equipment
Mobility Aids
2.2.4 Market Segmentation: By Product Type
final report
Illustrative

3. Market Dynamics

30
3.1 Market growth drivers
▪ Factors leading to the expansion of the elderly population in Kenya
involve increased wealth, enhanced health conditions, better nutrition,
and advancements in technology for the treatment, early detection, and
cure of diseases
▪ Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪ In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
2009 2019 2030
3.1.1 Number of older individuals rose by approximately 41% from 1,943,715 in 2009 to 2,740,040 in 2019, with a
majority of the elderly population being female
Increase of Geriatric population in Kenya
Illustrative

31
3.1 Market growth drivers (continued)
3.1.2 Non-communicable diseases (NCDs) like cardiovascular conditions, cancers, chronic respiratory ailments, and
diabetes are on the rise and anticipated to result in a twofold increase in associated fatalities by 2030
▪ Increase in non-communicable diseases (NCDs) in Kenya is,
in part, attributed to shifts in factors that can be modified,
including changes in diet and reduced physical activity
▪ Please be aware that this sample report is intended to
provide you with a brief overview of the kind of information
and analysis that will be presented in the final report
▪ In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Illustrative
2010 2020 2030
Prevalence of chronic disease in Kenya

32
3.1 Market growth drivers (continued)
3.1.3 Government initiatives and awareness campaigns in Kenya for home care
▪ Kenya Community Health Policy: - Aims to achieve objectives by optimizing community health services through efficient leadership,
credible human resources, financing, commodity supply, surveillance, and robust monitoring and evaluation, strengthening referral
mechanisms
▪ They promote home care for terminally ill and pregnant women
▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will
be presented in the final report
▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the
topic or subject matter of interest
Illustrative

33
3.2 Market restraints
3.2.1 Kenya faces a notable
shortage of healthcare
professionals
▪ In 2020, Kenya had 30.14
midwives and clinicians per
10,000 people, which is below
the World Health Organization's
recommended standard
▪ In order to obtain access to all
of the information that you are
seeking, you will need to
purchase the final report
▪ Final report will be
comprehensive and detailed,
and it will include data,
analysis, trends, and other
relevant information related to
the topic or subject matter of
interest
3.2.2 Regulatory challenges as
multiple licensing are required
▪ To establish a home healthcare
business, obtaining a business
permit, trading license, fire
clearance certificate, health
certificate, and various other
necessary documents is
essential
interest
3.2.3 High cost of home
healthcare product and
technological barriers
▪ Limited access and adoption of
advanced healthcare
technologies pose a constraint.
Some patients lack the
necessary tech literacy or
reliable internet access,
hindering the adoption of
telehealth solutions
interest
Our analysis will thoroughly investigate the key restraints that may significantly impact business
operations and growth.
Illustrative

4. Competitive Landscape

35
4.1 Key Company Profile
▪ Here is the list of top 10 companies which
will cover in the final report
▪ Each company will have slides for
o Overview
o Key details
o Offerings
o Name of products
o Recent activities/ Press Coverage
o Distribution and Vendor Partners
o Mergers, Acquisitions and
Collaboration
o Financials
▪ If there are specific companies that you
would like to be included in the report,
please let us know via email
1 Go Care
3 One Call Homecare
5 Upendo
7 Crystal Homecare
9 Sahara Homecare
2 Ella Homecare
4 E-tiba
6 Bena Care
8 Avenue Homecare
Kindred International
Homecare
10
Key Note:
Illustrative

36
4.1.1 Go Care
Founded in: 2011
HQ: Nairobi, Kenya
Type: Private
Revenue: $XX
Website: www.gocare.co.ke
▪ Their comprehensive home healthcare services cater to the elderly,
sick, terminally ill, and individuals with disabilities, fostering
independence and enabling them to live in the comfort of their homes.
▪ They prioritize the well-being of our clients by delivering quality care,
ensuring they receive the support needed for enhanced daily comfort
and dignity.
Solutions offered
➢ Home Based Care
➢ Therapy Services
➢ Training
➢ Equipment
Home Nursing Care Services Training & Equipment Provided
Diabetes Hypertension
Cancer Stroke
Dementia HIV/AIDS
Parkinson Accident Injuries
Post-Natal Care Post-Surgery Care
Wound Dressing
Illustrative
Established in 2018, GoCare Training Institute (GTI) offers
various programs, including full and part-time options,
evening and Saturday classes, and distance learning through
online platforms
They provide many equipment for buying or renting like blood
pressure monitors, glucometers, hospital/home care beds,
oxygen equipment, diagnostics

37
4.1.1 Go Care (continued)
Major Distribution Partners Major Vendor Partners
Partnerships Ecosystem
Illustrative

38
Company Name Type
Amount /
Duration
Year Key Pointers
Latest Deals - Mergers and Acquisitions
Illustrative

39
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Revenues ($Bn), 2020-2030
Breakdown of Net Revenue by Segment, 2022
1 2 3 4
report
▪ In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
interest
Illustrative

40
4.1.2 Company2
Founded in:
HQ:
Type:
Revenue:
Website:
Solutions offered by Company
Drugs Indications
Drugs for Cancer Recent Activity / Press Coverage
Illustrative

41
4.1.2 Company2 (continued)
Major Distribution Partners Major Vendor Partners
Partnerships Ecosystem
Illustrative

42
Company Name Type
Amount /
Duration
Year Key Pointers
Latest Deals - Mergers and Acquisitions
Illustrative

43
xx xx xx
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Revenues ($Bn), 2020-2030
report
▪ In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
interest
Breakdown of Net Revenue by Segment, 2022
1 2 3 4
Illustrative

5. Reimbursement Scenario

45
5.1 Reimbursement Regulation
The reimbursement scenario in the US cancer market is complex and can vary
depending on the specific treatment, setting of care, and insurance coverage.
Here are some key points to consider:
▪ Public Insurance:
o National Health Insurance Fund (NHIF) was formed in 1966, the NHIF
finances the healthcare system by mandating contributions from
individuals in the formal sector, including civil servants
o Membership extends to those in the informal or self-employed sector,
and the NHIF provides specific options tailored for retirees
▪ Private Insurance:
o Private insurance coverage for cancer treatments can also vary widely
depending on the insurer and the specific policy
o Some policies may have high out-of-pocket costs, such as deductibles
and co-pays, while others may have more comprehensive coverage
Public Insurance provide health
insurance coverage for more than 4 in 10
kanya population
Medicare
17%
Medicaid
and CHIP
21%
Employer-Sponsored
49%
Other Private
3%
Other Public
1%
Uninsured
9%
Health Insurance Coverage, 2022
Illustrative

46
5.1 Reimbursement Regulation (continued)
Coverage Penetration (% Total Population) Source of Funding
Spend on Healthcare (%of Current Health Expenditure)
Reimbursement Market Trends
 Public healthcare coverage is provided by the government and includes programs like
Public and Private
 Public is a federal program that provides healthcare coverage to individuals who are
65 years of age or older, as well as certain younger people with disabilities
 Private is a joint federal-state program that provides healthcare coverage to
individuals with low income and limited resources
▪ Shift towards value-based care has been a significant trend in the Kenya healthcare system, with payers and providers increasingly focused on improving patient
outcomes and reducing costs
▪ This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which
incentivize providers to deliver high-quality, cost-effective care
2017 2018 2019 2020 2021 2022 2023
Government Expenditure
Private Health Insurance
Out of Pocket
Other
NA NA
2012 2013 2014 2015 2016
Public Healthcare
Coverage
Private Coverage
6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy)
14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy)
Illustrative

Life-sciences Market Research
Reports you can trust
www.insights10.com
We maintain an extensive database comprising
over 30,000 syndicated market research reports
within the pharmaceuticals and healthcare sector,
offering a global, regional, and country-level
perspective. Our services also include the provision
of customized research reports, meticulously
tailored to align with your specific requirements.

At Insights10, our extensive report
library spans a diverse range of
categories within the field of life
sciences.
Market Research
Reports across various
categories in healthcare
www.insights10.com
Digital
Health
Medical
Devices
Healthcare
Services
Rare
Diseases
Clinical
Trials
OTC &
Nutraceuticals
Pharma
(Diseases
& Drugs)

Click on the country to see the reports available
Global Coverage
North America
• US
• Canada
Latin America
• Brazil
• Argentina
• Mexico
• Ecuador
• Venezuela
• Senegal
Europe
• UK
• Germany
• France
• Italy
• Spain
• Russia
• Netherlands
• Sweden
• Romania
• Switzerland
• Poland
• Austria
• Ireland
• Norway
• Denmark
• Belgium
• Portugal
• Ukraine
• Bulgaria
• Finland
APAC
• India
• China
• South Korea
• Japan
• Australia
• Indonesia
• Hong Kong
• New Zealand
• Philippines
• Singapore
• Malaysia
• Thailand
• Vietnam
Middle East
• UAE
• Saudi Arabia
• Turkey
• Lebanon
• Kuwait
• Qatar
Africa
• Egypt
• Kenya
• South Africa
• Algeria
• Nigeria
• Libya
• Tanzania
• Morocco

What do our reports cover?
Market Overview
Growth Drivers & Growth Restraints
Epidemiology & Disease type
Market Size & Forecast
Competitive Landscape
Policy & Regulatory Landscape
Reimbursement Scenario
Recent Developments
Market Segmentation Factors Driving Future Growth
1
2
3
4
5
6
7
8
9
10

01 03
02 04 05
Define
precise
research
questions
Validate data
through primary
research
interviews
Gather data
through
secondary
research
Forecast
market size
and segment
analysis
Extract key
insights from
the research
findings
06
Compile &
present a
comprehensive
analytical report
Our Research Process

Bottom Up Approach
Analyze product or treatment pricing
and reimbursement strategies
Evaluate consumer or patient
demographics and numbers
Predict future market
growth or decline based
on key market trends &
dynamics
Find
final
market size
Top Down Approach
Examine the total healthcare expenditure in
the targeted disease or service domain.
Assess the proportion of spending
allocated to the specific product or
treatment category.
Predict future market
growth or decline
based on key market
trends & dynamics
Find
final
market
size
Data Triangulation & Data Validation

2022
2023-
2030
Report Attribute
Quantitative Units
Pricing and Purchase
Revenue in USD Million/Billion (Mn/Bn)
Our pricing and purchase options are adaptable to
suit the specific scope of work.
Details
Time Frame
Base
Year for
estimation
Forecast
Period
Report Scope
Delivery Timeline
Typically, the delivery of the final report falls within a
timeframe of 5 to 7 business days, but the exact
duration may vary depending on the project's scope.
Customization
We are pleased to offer you the option of
customizing the report to align with your specific
research requirements at no extra charge, provided
it falls within the defined scope of the project.

We have access to a multitude of highly
dependable data sources, supported by
years of experience that guide us in
discerning which sources are most reliable
and current for the specific information
needed.
Access to credible
data sources for
secondary research
www.insights10.com
Statistical
Databases
Annual
Reports
Trade
Publications
Online
Databases
Published
Research
Reports
White-
papers
Press
Releases

Reliable
Expert Verified
Realistic
Comprehensive
Easy to read
Our reports present data, which is
The report is prepared using a proven methodology and insightful
research
The report is prepared by a team of highly qualified & experienced
research analysts & vetted by our local associates
The report allows you to confidently make smarter business and
strategic decisions based on realistic findings
Covers everything you would need to know about the market
including market size, competitive analysis & much more
You do not have to be a market expert to understand what really is
happening on the market and how it works

Yearly Access
(Subscription)
Regulatory
Compliance
Competitive
Intelligence
Conference
Coverage
Full-Time
Engagement
Database Service
& KOL Mapping
Primary Research &
Interviews
Customized Market
Research Reports
Syndicated Market
Research Reports
Our Services

“The business decision-making process is no longer as
straightforward as it used to be. It requires insights
generated at the right time, based on reliable data
interpreted in a nuanced manner for each market. We at
Insights10 are building the future of market research and
are committed to providing our clients with the right
intelligence and insights to make business decisions
quickly and efficiently.
Insights10 is a unique platform that combines deep
domain expertise, nuanced data at a country and
functional area level, and years of experience working with
some of the best organizations in the world, generating
insights that provides substantial competitive advantage.”
Dr. Purav Gandhi, Founder & CEO
Click to watch Our Introductory Video here
CEO Speaks

Purav is a physician and an
entrepreneur with 12+ years of
experience in Healthcare & Life
Sciences industry spanning across
strategy, market access, health
informatics and RWE, digital health,
analytics and data science. Purav
studied medicine from Gujarat
University and also completed his MBA
from IIM-Kozhikode. Purav started his
career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Anish has 15+ years of
experience in management
consulting in the Life Sciences
sector, and has worked with
diverse multinational firms in
the US, India, Middle East and
APAC regions. His primary area
of interest is Customer and
Market Strategy, Market
Access, and Digital Health with
special focus on emerging
markets like Africa, Middle East
and APAC.
Dr. Purav Gandhi
Founder & CEO
Anish Swaminathan
Director
Mukesh is an engineering graduate with
an MBA in Marketing. He is a seasoned
healthcare market research &
marketing professional with a
progressive experience of over 20
years in Life Sciences, Healthcare
services, Pharma and Medical Device
sectors. With an in-depth understanding
of primary research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare &
completed several research projects
across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across
diff. markets (America, Europe, Africa,
APAC and Middle East). Her areas of
expertise include: Indentifying emerging
trends in life sciences industry,
Competitor landscape assessment,
Disease opportunity assessments etc.
She is a pro in secondary and primary
research with a deep domain expertise
in healthcare sector.
Mukesh Nayak
Head – Marketing & Research
Ritu Baliya
Engagement Manager
Leadership Team

… and many more
Pi-SM
GmbH
Our Clients

I've had the pleasure of availing Insights10’s services several times, and I've always
been impressed by their expertise, professionalism, and dedication to providing us with
the highest quality data and insights. Whether one is looking to launch a new product,
expand into a new market, or better understand one's target customers, Insights10
insures achieving the goals.
Their team of experts has a deep understanding of the healthcare industry, and they use
their knowledge to develop customized research solutions that meet the specific needs
of each client. I highly recommend Insights10 to anyone looking for a reliable and
experienced partner in healthcare market research. They're a valuable asset to any
company that wants to succeed in this dynamic sector.
Sid Panigrahy
Founder-CEO, MediGlobo Inc.,
(Healthcare - Group Company of Omi Holdings, Inc) Tampa, Florida (USA)
What our clients say

Dear Insights10 Team, I wanted to thank you all for the great work you conducted
producing the Kenya Medical and Diagnostic Laboratory Service Market Analysis. The
quality of the report was excellent, and you managed to complete it in record time. I was
also impressed by your quick turnaround on the topics discussed as a follow up after the
report's first version; you managed to gather the information required, plus a very good
analysis.
I will definitely consider working with you again if the opportunity arises, and will not
hesitate in recommending you to colleagues working in the field Thank you again for
your professionalism and team work. It was a pleasure working with you.
Lelio Marmora
CEO, The Management Lab, Geneva
Ex. Executive Director, UNITAID

Michael Blumberg Youssef Mallat
Wissem Menad
Dr. Robert Ryan
Co Founder GFAU Pty Ltd., Australia
Co Founder – Embi, Optimum Oral care, Australia
Opusline, A part of Accenture, Paris
Senior Manager Segment Marketing
Performance Health, London, UK
Chief Executive Officer, Innova Therapeutics, Inc., USA
We engaged INSIGHTS10 to assist us with our research requirements
for the Oral Care Market sector in Australia. We been very impressed
with the depth and quality of data and equally with the personal
service we experience from the management team on our account.
They understand our business, our challenges and our goals. There is
a real sense of partnership as we continue to work together.
The info you delivered on the European Patient
Support Market with a deep dive into countries
like Spain, Germany, Italy, France, UK and
Belgium, was very useful.
Insights10 has been a great resource for
getting a detailed report on the UK
Physiotherapy Market. Usually I had multiple
sources for getting global reports, but now I
can get in-depth country reports from
Insights10 which has been a game changer.
We were looking for very specific information regarding Abu Dhabi
Oncology Drugs Market. The insights provided by Insights10 is
fantastic and they just took less than three days to deliver the report.

Thank You
www.insights10.com
Email: insights@insights10.com
India: (+91) 931 639 7935
We would be happy to help.
Do you have
any questions?

Kenya Home Healthcare Market Analysis

Recommended

Recommended

More Related Content

Similar to Kenya Home Healthcare Market Analysis

Similar to Kenya Home Healthcare Market Analysis (20)

More from Insights10

More from Insights10 (20)

Recently uploaded

Recently uploaded (20)

Kenya Home Healthcare Market Analysis